Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 13.5264.41--

What is the latest Core EBITDA Growth ratio of AARTI PHARMALABS ?

The latest Core EBITDA Growth ratio of AARTI PHARMALABS is 13.52 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202413.52
Mar202364.41
Mar2022-
Mar2021-

How is Core EBITDA Growth of AARTI PHARMALABS Trending?

Years Core EBITDA Growth % Change
Mar2024 13.52
-79.01
Mar2023 64.41
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Growth ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹7,650.7 Cr -1.7% -8.5% 23% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹380,594.0 Cr -3.3% -6.9% -9.7% Stock Analytics
DIVIS LABORATORIES ₹162,722.0 Cr 1.7% -6.8% 25.4% Stock Analytics
CIPLA ₹127,508.0 Cr -0.9% 0.5% -0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,111.0 Cr -1.9% -1.3% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,225.0 Cr -1.2% -2% -9% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-1.7%

-8.5%

23%

SENSEX

-2.2%

-1.7%

-1.2%


You may also like the below Video Courses